TipRanks
pc:sig46

Sightera Biosciences

Galileilaan 15 Darwin Incubator Antwerp, Flemish Region 2845, BE
https://www.sightera-biosciences.com/
Sightera Biosciences develops AI-driven drug discovery by converting clinically correlated, patient-derived biology and drug-response datasets into generative models for small-molecule design. The company builds proprietary, biomarker-linked datasets and applies machine learning to generate first-in-class small molecules with distinct mechanisms of action for targeted patient populations. Founded as a tech‑bio spin-out from the University of Antwerp and the University Hospital of Antwerp, Sightera combines translational biology, medicinal chemistry, and data science to advance precision therapeutic discovery.

Leadership & Board

Key Executives
CEOHendrik Vercammen
FounderMaxim Le Compte
FounderLars Vanlommel
FounderChristophe Deben
Current Number of Employees6
Current LinkedIn Followers1,614

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$3M
Total Amount Raised$3M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$3M
Latest Funding Amount$3M
Latest Funding RoundPre-Seed
Latest Funding RoundPre-Seed
Post-Money Valuation―
Post-Money Valuation―

Employee Trend

Sightera Biosciences had 6 employees as of September 28, 2026. The number of employees increased by 1 (20.00%) week-over-week.
6Latest Employee Count
1(20.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Sightera Biosciences had 1,614 followers as of September 28, 2026. The number of followers increased by 15 (0.94%) week-over-week.
1,614Latest Followers Count
15(0.94%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 21, 2026
Pre-Seed
$3.43M
―

Similar Companies

A snapshot of private companies similar to Sightera Biosciences, helping you discover and navigate related company profiles.

Related News and Analysis